Skip to main content
Premium Trial:

Request an Annual Quote

Courtagen nucSEEK Focus, epiSEEK Focus

Courtagen Life Sciences has launched the nucSEEK Focus Nuclear Mitochondrial Gene Panel and epiSEEK Focus Epilepsy and Seizure Disorder Panel. The new next-generation sequencing tests will complement the company's current nucSEEK Comprehensive Nuclear Mitochondrial Exome Panel and epiSEEK Comprehensive Epilepsy and Seizure Disorder Panel, respectively, Courtagen said. NucSEEK Focus includes 181 genes associated with mitochondrial disorders, while epiSEEK Focus includes 76 genes associated with epilepsy and seizure disorders, including early and adult onset disease types.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.